HUE054315T2 - Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof - Google Patents
Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therofInfo
- Publication number
- HUE054315T2 HUE054315T2 HUE14837858A HUE14837858A HUE054315T2 HU E054315 T2 HUE054315 T2 HU E054315T2 HU E14837858 A HUE14837858 A HU E14837858A HU E14837858 A HUE14837858 A HU E14837858A HU E054315 T2 HUE054315 T2 HU E054315T2
- Authority
- HU
- Hungary
- Prior art keywords
- binding
- specific monovalent
- monovalent diabodies
- uses therof
- therof
- Prior art date
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361869510P | 2013-08-23 | 2013-08-23 | |
US201361907749P | 2013-11-22 | 2013-11-22 | |
EP13198784.4A EP2839842A1 (en) | 2013-08-23 | 2013-12-20 | Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof |
US201461990475P | 2014-05-08 | 2014-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE054315T2 true HUE054315T2 (en) | 2021-08-30 |
Family
ID=65632998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE14837858A HUE054315T2 (en) | 2013-08-23 | 2014-08-20 | Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof |
Country Status (9)
Country | Link |
---|---|
CL (1) | CL2016000362A1 (en) |
DK (1) | DK3035965T3 (en) |
ES (1) | ES2860973T3 (en) |
GE (1) | GEP20197053B (en) |
HK (1) | HK1225999A1 (en) |
HR (1) | HRP20210215T1 (en) |
HU (1) | HUE054315T2 (en) |
LT (1) | LT3035965T (en) |
UA (1) | UA119539C2 (en) |
-
2014
- 2014-08-20 ES ES14837858T patent/ES2860973T3/en active Active
- 2014-08-20 HU HUE14837858A patent/HUE054315T2/en unknown
- 2014-08-20 UA UAA201602538A patent/UA119539C2/en unknown
- 2014-08-20 GE GEAP201414100A patent/GEP20197053B/en unknown
- 2014-08-20 LT LTEP14837858.1T patent/LT3035965T/en unknown
- 2014-08-20 DK DK14837858.1T patent/DK3035965T3/en active
-
2016
- 2016-02-17 CL CL2016000362A patent/CL2016000362A1/en unknown
- 2016-12-22 HK HK16114613A patent/HK1225999A1/en unknown
-
2021
- 2021-02-08 HR HRP20210215TT patent/HRP20210215T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CL2016000362A1 (en) | 2016-10-28 |
GEP20197053B (en) | 2019-12-25 |
HK1225999A1 (en) | 2017-09-22 |
DK3035965T3 (en) | 2021-02-15 |
LT3035965T (en) | 2021-04-12 |
UA119539C2 (en) | 2019-07-10 |
ES2860973T3 (en) | 2021-10-05 |
NZ716914A (en) | 2021-09-24 |
HRP20210215T1 (en) | 2021-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL244237B (en) | Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof | |
IL251377B (en) | Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof | |
HK1226000A1 (en) | Bi-specific monovalent diabodies that are capable of binding to gpa33 and cd3, and uses thereof | |
HK1249423A1 (en) | Bispecific monovalent diabodies that are capable of binding b7-h3 and cd3, and uses thereof | |
IL244009B (en) | Bi-specific monovalent fc diabodies that are capable of binding cd32b and cd79b and uses thereof | |
ZA201701341B (en) | Bispecific her2 and cd3 binding molecules | |
AP2016009475A0 (en) | Bispecific antibodies that bind to cd38 and cd3 | |
IL247590A0 (en) | Bi-specific antibodies and uses thereof | |
EP3194438C0 (en) | Antibodies binding to bmp4, and uses thereof | |
HK1225999A1 (en) | Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses thereof | |
TH1601000783A (en) | Bi-specific monovalent diabodies capable of binding CD123 and CD3, and their uses |